| Head of Strategic Access and Partnerships |
Mumbai (Head Office) |
India |
International |
Innovative Medicines |
Market Access |
Nov 04, 2024 |
| Supervisor, Specialty Pharmacy Triage Coordinator |
Arizona |
USA |
US |
Innovative Medicines |
Market Access |
Nov 03, 2024 |
| V&A Specialist |
Taipei |
Taiwan |
International |
Innovative Medicines |
Market Access |
Nov 03, 2024 |
| Health Economics and Outcomes Research Manager |
London (The Westworks) |
United Kingdom |
International |
Innovative Medicines |
Market Access |
Nov 01, 2024 |
| Associate Director, HEOR Product Lead-Neuroscience/ GTx |
Remote Position (USA) |
USA |
US |
Innovative Medicines |
Market Access |
Oct 29, 2024 |
| Director, HEOR Product Lead-Immunology |
Remote Position (USA) |
USA |
US |
Innovative Medicines |
Market Access |
Oct 29, 2024 |
| Strategic Account Manager - Wales |
Field Force (England / Wales) |
United Kingdom |
International |
Innovative Medicines |
Market Access |
Oct 28, 2024 |
| Associate Director RWE Manager |
Dublin (Novartis Corporate Center (NOCC)) |
Ireland |
Operations |
CTS |
Market Access |
Oct 25, 2024 |
| Transformation Strategy Manager Jr |
Santo Amaro |
Brazil |
International |
Innovative Medicines |
Market Access |
Oct 25, 2024 |
| US Market Access Future Leaders Program |
East Hanover |
USA |
US |
Innovative Medicines |
Market Access |
Oct 18, 2024 |
| AD, Access & Reimbursement - Minneapolis - Remote |
Field Non-Sales (USA) |
USA |
US |
Innovative Medicines |
Market Access |
Oct 17, 2024 |
| Associate Director, Access & Reimbursement RLT - San Diego, CA - Remote |
Field Non-Sales (USA) |
USA |
US |
Innovative Medicines |
Market Access |
Oct 17, 2024 |
| Pricing Manager |
Dublin (Country President Office (CPO)) |
Ireland |
International |
CTS |
Market Access |
Oct 16, 2024 |
| AD, Market Access TA Strategy- Breast & Women's Cancer |
East Hanover |
USA |
US |
Innovative Medicines |
Market Access |
Oct 16, 2024 |
| Manager Economic Modelling |
Hyderabad (Office) |
India |
Operations |
CTS |
Market Access |
Oct 16, 2024 |
| Senior Patient Access Lead |
Lithuania |
Lithuania |
International |
Innovative Medicines |
Market Access |
Oct 14, 2024 |
| Value Access Manager |
Bogota (Oncology) / Cali (Pharmaceuticals) |
Colombia |
International |
Innovative Medicines |
Market Access |
Oct 10, 2024 |
| Head of MA South |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Market Access |
Oct 10, 2024 |
| Director Account Management and Pricing Strategy - Remote |
Remote Position (USA) |
USA |
US |
Innovative Medicines |
Market Access |
Oct 08, 2024 |
| Manager, Evidence Generation |
Hyderabad (Office) |
India |
Operations |
CTS |
Market Access |
Oct 03, 2024 |
| Senior Market Access Manager |
New South Wales (NSW) |
Australia |
International |
Innovative Medicines |
Market Access |
Sep 30, 2024 |
| P&R Manager |
Seoul |
South Korea |
International |
Innovative Medicines |
Market Access |
Sep 27, 2024 |
| Innovative Access Partnerships and Engagement Manager |
İstanbul Kavacık |
Türkiye |
International |
Innovative Medicines |
Market Access |
Sep 03, 2024 |
| Senior Public Affairs Manager (m/f/d) |
Berlin West (Non-Sales Force) (Novartis Pharma GmbH) |
Germany |
International |
Innovative Medicines |
Market Access |
Sep 03, 2024 |
| Market Access Specialist |
Hefei (Anhui Province) |
China |
International |
Innovative Medicines |
Market Access |
Sep 03, 2024 |
| Solution & Service Design Manager |
London (The Westworks) |
United Kingdom |
International |
Innovative Medicines |
Market Access |
Aug 15, 2024 |
| Real World Evidence Research Analyst |
Dublin (Novartis Corporate Center (NOCC)) |
Ireland |
Operations |
CTS |
Market Access |
Aug 12, 2024 |
| Pricing Manager |
New South Wales (NSW) |
Australia |
International |
Innovative Medicines |
Market Access |
Jul 31, 2024 |
| New Products & Strategic Pricing Partner |
Kyiv |
Ukraine |
International |
Innovative Medicines |
Market Access |
Apr 16, 2024 |
| Patient Access Lead |
Kyiv |
Ukraine |
International |
Innovative Medicines |
Market Access |
Apr 16, 2024 |